pros and cons of glp-1 weight loss medications have significant side effects GLP-1 Medications for Weight Loss:

Shares of Zealand Pharma and Roche (RHHBY) fell 11% and 2%, respectively, on Thursday morning just a day after popping on news of their collaboration to develop new weight-loss treatments

Plasma metabolites predict severity of depression and suicidal ideation in psychiatric patients-a multicenter pilot analysis

Inhibition of SGLT-1 in the small intestine causes more glucose transport to the distal intestine and colon, resulting in greater fermentation of glucose to SCFAs by luminal bacteria and increased sustained release of GLP-1 in the distal intestine [174] (Fig

Poison centers say they are most often contacted about accidental errors like taking doses too close together or taking a higher-than-recommended dose at once